Blood glucose should be monitored hourly for 4–6 h after glucose–insulin therapy due to hypoglycemia risk [17, 18], which is more common in patients with kidney impairment, no diabetes, low baseline glucose, low body weight, or female sex [15]. Here, INS is linked to Hypoglycemia.